Home Search
geovax - search results
If you're not happy with the results, please do another search
GeoVax to Present at the 2024 BIO CEO & Investor Conference
ATLANTA, GA, Feb. 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious...
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial!
Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants
We were having cocktails at a fancy restaurant last night with a hedge fund manager, who manages...
GeoVax Labs (GOVX) JP Morgan 2024 Healthcare Conference Transcript.
ILLUSTRATION 3 |MISSION AND STRATEGY
Our mission: One is to innovate. The other one is to differentiate. The other one is to accelerate and finally...
Adding GeoVax (GOVX) $3.32 to Reverse Stock Split Watch List.
Okay, Here's Our First Name for the Reverse Stock Split, Watch List. We'll Venture to Have 10 Names Added to Watch List Within 30...
Adding Geovax (GOVX) to 2024 Biotech Watch List.
GEOVAX (GOVX) $0.32
We added this to the Watch List earlier in the week and then AFTER speaking to CEO David Dodd and the Head...
GeoVax Labs (GOVX) Video Presentation.
GeoVax’s COVID-19 vaccine candidates, which can induce strong antibody and T cell responses against the variants of the SARS-CoV-2 virus, also offers the possibility...
GeoVax (GOVX) Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox.
ATLANTA, GA, Dec. 19, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and...
Adding GeoVax (GOVX) $0.52 to Watch List.
Report Out Next Week. Head's Up.
Price and time-stamping our returning interest at $0.52.
We're headed to the Dawson James Investor Conference tomorrow to see...
Bridging the Immunity Gap: An In-Depth Conversation with GeoVax’s (GOVX) CEO, David Dodd
In an era of rapid scientific development, the pharmaceutical industry constantly evolves to meet new challenges and seize emerging opportunities. GeoVax, a biotechnology company...
Gold, Silver & Critical Minerals Update.
Like with Most in Precious Metals, Our Ideas are Performing Rather Well.
And we have a new name! Adding Americore Resources (AMCOF) $0.54, to...
Latest article
Fairchild Gold Corp., Presenting at Palm Beach Investor Roadshow.
Vancouver, British Columbia and Las Vegas, Nevada--(Institutional Analyst - April 8th, 2026) - Fairchild Gold Corp. (TSXV: FAIR) (FSE: Y4Y) (OTCQB: FCHDF) ("Fairchild" or the "Company"),...
Precious Metals Analyst | Mark Reichman | Noble Capital
Mark Reichman
Senior Research Analyst, Industrials and Basic Industries
BIO
Mark joined Noble as a senior research analyst with coverage responsibility in the Industrials and Basic Industries...
